Glycosylation inhibitor 2-deoxy-d-glucose, in combination with TRAIL, synergistically induced apoptosis in oral cancer KB cells via the upregulation of DR5 [15]. The gene discussed is TNFRSF10B; the disease is lip and oral cavity carcinoma.